Price (90d)
No price history yet — the daily price refresh runs once a day.
Signal Score (90d)
95Quote
Valuation & Ratios
Returns & Efficiency
Revenue & Net Income (Annual)
| Fiscal Year | Revenue | Net Income | EPS |
|---|---|---|---|
| 2026 | $4.20M | $-6.10M | $-0.01 |
| 2025 | $4.94M | $-4.04M | $-0.01 |
| 2024 | $4.75M | $-7.63M | $-0.02 |
| 2023 | $3.95M | $-5.40M | $-0.01 |
| 2022 | $111.0K | $-1.64M | $-0.00 |
Social Signal Score
Earnings
Thu, Aug 27(in 11 days)
Estimates and results for TRUFF via Financial Modeling Prep. Beating consensus says the company cleared the bar analysts set, not that the business grew.
Valuation
TRUFFhas no positive reported earnings per share, so an earnings-multiple projection can't be built for it. Companies are valued on other measures at this stage — revenue growth, cash burn, or book value — none of which this calculator models.
Mentions (1)
- Newsnewsfilecorp.com·1d ago·Neutral
…the treatment of depression in Parkinson's disease. Toronto, Ontario--(Newsfile Corp. - August 14, 2026) - Rhelion Life Sciences Corp. (CSE: RHEL) (FSE: 4YX) (OTCQB: TRUFF) ("Rhelion" or the "Company") an Ontario-based organization advancing innovation and research within the legal psychedelic sector.
View source ↗